We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$489B
AUM Growth
+$8.01B
Cap. Flow
-$30B
Cap. Flow %
-6.13%
Top 10 Hldgs %
29.25%
Holding
15,615
New
1,894
Increased
5,213
Reduced
6,341
Closed
1,909

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.71B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$613M
3
AAPL icon
Apple
AAPL
+$478M
4
MA icon
Mastercard
MA
+$450M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$424M

Sector Composition

Rank Sector Weight
1 Technology 3.06%
2 Financials 2.32%
3 Consumer Discretionary 2.21%
4 Healthcare 2.2%
5 Communication Services 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEON icon
13351
CALL
VEON
VEON
$3.62B
$31K ﹤0.01%
736
+100
+16% +$4.88K
SEEL
13352
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$31K ﹤0.01%
5
-13
-72% -$99.8K
KA
13353
PUT
DELISTED
Kineta, Inc. Common Stock
KA
$31K ﹤0.01%
+1,500
New +$64.9K
ARAV
13354
CALL
DELISTED
Aravive, Inc. Common Stock
ARAV
$31K ﹤0.01%
14,000
-40,100
-74% -$133K
LMDXW
13355
DELISTED
LumiraDx Limited Warrant
LMDXW
$31K ﹤0.01%
21,431
-314
-1% -$507
CRXT
13356
DELISTED
Clarus Therapeutics Holdings, Inc. Common Stock
CRXT
$31K ﹤0.01%
+12,597
New +$54.7K
CBUS icon
13357
PUT
Cibus
CBUS
$147M
$30K ﹤0.01%
+286
New +$41.5K
FTK icon
13358
Flotek Industries
FTK
$852M
$30K ﹤0.01%
+4,495
New +$25.5K
HYMC icon
13359
Hycroft Mining Holding Corp
HYMC
$1.82B
$30K ﹤0.01%
4,929
+2,742
+125% +$31.2K
ICUCW
13360
SeaStar Medical Holding Corp Warrant
ICUCW
$324K
$30K ﹤0.01%
65,438
+101
+0.2% +$50
TRX icon
13361
CALL
TRX Gold Corp
TRX
$254M
$30K ﹤0.01%
76,500
-3,200
-4% -$1.39K
SGTX
13362
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$30K ﹤0.01%
+838
New +$47.7K
RAAS
13363
PUT
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
$30K ﹤0.01%
3,400
-8,933
-72% -$101K
ODT
13364
PUT
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$30K ﹤0.01%
22,400
-11,500
-34% -$27.2K
CEMI
13365
CALL
DELISTED
Chembio diagnostics, Inc.
CEMI
$30K ﹤0.01%
25,900
-27,700
-52% -$56.4K
GYRE icon
13366
Gyre Therapeutics
GYRE
$641M
$29K ﹤0.01%
4,202
-4,519
-52% -$77.3K
IBIO icon
13367
PUT
iBio
IBIO
$69.5M
$29K ﹤0.01%
107
-113
-51% -$43.1K
KRKR
13368
36Kr Holdings
KRKR
$5.68M
$29K ﹤0.01%
1,365
+326
+31% +$9.56K
PHIO icon
13369
Phio Pharmaceuticals
PHIO
$11.8M
$29K ﹤0.01%
269
+18
+7% +$2.86K
PLUR icon
13370
Pluri
PLUR
$16.7M
$29K ﹤0.01%
2,462
-4,800
-66% -$94.9K
UAMY icon
13371
CALL
United States Antimony
UAMY
$751M
$29K ﹤0.01%
58,100
-5,300
-8% -$3.9K
PHLT
13372
CALL
DELISTED
Performant Healthcare Inc
PHLT
$29K ﹤0.01%
+11,900
New +$35.4K
VINO
13373
DELISTED
Gaucho Group Holdings, Inc. Common Stock
VINO
$29K ﹤0.01%
11
-2
-15% -$6.88K
ATNX
13374
CALL
DELISTED
Athenex, Inc. Common Stock
ATNX
$29K ﹤0.01%
1,070
-1,365
-56% -$57.6K
GLDG
13375
GoldMining Inc
GLDG
$178M
$28K ﹤0.01%
22,860
-23,332
-51% -$30.3K

Similar funds

Citadel Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Citadel Advisors held 15,615 positions worth $489B, up 1.7% from $481B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors withdrew a net $30B in Q4 2021, closing 1,909 positions and reducing 6,341 holdings. Its most notable exit was CIMAREX ENERGY CO, an estimated $279M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $248M.

  • Citadel Advisors's largest Q4 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,847,920 shares worth $248M.
  • Citadel Advisors added most to Amazon in Q4 2021, an estimated $802M increase.
  • Citadel Advisors's biggest Q4 2021 reduction was Tesla, cutting an estimated $1.71B.
  • Citadel Advisors fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $279M.
  • Citadel Advisors's ten largest holdings make up 29% of its $489B portfolio in Q4 2021.
  • Citadel Advisors opened 1,894 new positions and closed 1,909 in Q4 2021.
  • Citadel Advisors's portfolio value rose 1.7% quarter-over-quarter to $489B.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.